未登录 分享 收藏
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study Nivolumab联合治疗晚期胃癌和胃食管交界癌患者: II期胃癌研究 Ku, G.; Haag, G. M.; Park, H.; Lam, V. K.; George, T. J.; Kim, S. S.; Gutierrez, M.; Shankaran, V.; Stein, S.; Denlinger, C. S.; Elimova, E.; Nagrial, A.; He, A. R.; Sawyer, M. B.; Yoon, H. H.; Geva, R.; Starr, J.; Curigliano, G.; Golan, T.; von Moos, R.; Fritsch, R.; Lim, D.; Wang, Q.; Patel, A.; Aoyama, T.; Lei, M.; Greenawalt, D.; Di Bartolomeo, M. 分享 收藏
Final results from phase I, first-in-human, dose escalation study of a first-in-class anti-ILT2 antibody, SAR444881, alone and with pembrolizumab or cetuximab, in patients with advanced solid tumors I期首次人体剂量递增研究的结果，该研究评估了第一类抗ILT2抗体SAR444881单药及联合pembrolizumab或cetuximab在晚期实体瘤患者中的疗效。 Perets, R.; Stemmer, S. M.; Geva, R.; Golan, T.; Fakih, M.; Cohen, J. E.; Lieu, C.; Jin, Z.; Lorusso, P.; Friedman, I.; Hakim, M.; Ziv, D. Haves; Hashmueli, S.; Mandel, I.; Ben Moshe, T.; Crawford, N.; Abbadessa, G.; Perez, R.; Wu, M.; Borad, M. 分享 收藏
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data Brenner, B.; Shulman, K.; Hubert, A.; Man, S.; Geva, R.; Ben-Aharon, I.; Fennig, S.; Mishaeli, M.; Yarom, N.; Bar-Sela, G.; Brenner, R.; Shai, A.; Baehner, F. L.; Russell, C.; Soussan-Gutman, L.; Voet, H.; Bareket-Samish, A.; Liebermann, N. 分享 收藏
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial (vol 42, pg 145, 2024) CXCR2拮抗剂navarixin联合pembrolizumab治疗晚期实体瘤: 一项2期随机试验 (第42卷，145页，2024) Armstrong, Andrew J.; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller Jr, Wilson H.; Hansen, Aaron R.; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J.; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S. 分享 收藏
Results from a phase 1 study of the anti-immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830 plus pembrolizumab in patients with previously treated advanced solid tumors Siu, Lillian L.; Gil-Martin, Marta; Cho, Byoung Chul; Perets, Ruth; Hilton, John; Geva, Ravit; Lugowska, Iwona; Gutierrez, Martin; Bonomi, Marcelo; Dziadziuszko, Rafal; Rasco, Drew; Ben-Ami, Eytan; Rodriguez, Cristina P.; Siddiqi, Shabana; Myer, Nicole; Suttner, Leah; Wilson, Douglas; Akala, Ombololaji O.; de Miguel, Maria 分享 收藏
Early activity and biomarker evaluation of NT219 in combination with cetuximab in a Phase 1/2 study of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) Rosenberg, Ari J.; Kato, Shumei; Johnson, Daniel; Popovtzer, Aron; Chiu, Vi K.; Geva, Ravit; Ben-David, Hava; Meirson, Tomer; Schickler, Michael; Reuveni, Hadas 分享 收藏
Intratumoral (ITu) delivery of mRNA-2752 encoding human OX40L/IL-23/IL-36γ in combination with durvalumab induces an immunostimulatory effect within the tumor microenvironment (TME) of patients with advanced solid tumors Abadier, Michael; Sullivan, Ryan J.; Chow, Jacky; Sehgal, Vasudha; Sweis, Randy F.; Daud, Adil; Shapira-Frommer, Ronnie; Perets, Ruth; Kummar, Shivaani; McKean, Meredith; Geva, Ravit; Patel, Manish R.; Khattak, Adnan; Fernandez-Penas, Pablo; Zacharek, Sima; Wahl, Natalia; Walker, Russell M.; Linh Van; Aanur, Praveen; Ward, Jim; Do, Khanh T.; Long, Georgina V. 分享 收藏
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial CXCR2拮抗剂navarixin联合pembrolizumab治疗晚期实体瘤: 一项2期随机试验 Armstrong, Andrew J.; Geva, Ravit; Chung, Hyun Cheol; Lemech, Charlotte; Miller Jr., Wilson H.; Hansen, Aaron R.; Lee, Jong-Seok; Tsai, Frank; Solomon, Benjamin J.; Kim, Tae Min; Rolfo, Christian; Giranda, Vincent; Ren, Yixin; Liu, Fang; Kandala, Bhargava; Freshwater, Tomoko; Wang, Judy S. 分享 收藏
分享 收藏
A novel endoscopic ultrasound guided extended-release siRNA implant targeting KRASG12D/V in localized pancreatic cancer Varghese, A. M.; Golan, T.; Schattner, M.; Ang, C.; Gutierrez, M.; Passhak, M.; Geva, R.; Yarom, N.; Ligresti, R.; Khamaysi, I.; Bhutani, M. S.; Matalon, S.; Pollack-Shragai, O.; Rom, D. M.; Shirvan, M.; Javle, M.; O'Reilly, E. M. 分享 收藏
Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor Geva, R.; Vieito Villar, M.; Ramon, J.; Perets, R.; Pedregal, M.; Corral de la Fuente, E.; Doger de Speville, B.; Calvo, E.; Bardina, J.; Garralda, E.; Brown, R. J.; Gregor, J.; Wu, S.; Steinbach, D.; Tsun-wen, S.; Cao, Y.; Lauring, J.; Moreno Garcia, V. 分享 收藏
Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity 无功能胰腺神经内分泌肿瘤 (nf-pnet) 中的血糖异常: 对一个未得到认可的实体的进一步见解 Osher, Esther; Geva, Ravit; Wolf, Ido; Tordjman, Karen; Klausner, Joseph; Sofer, Yael; Scapa, Erez; Shibolet, Oren; Shor, Dana Ben-Ami; Bar-Yishay, Iddo; Lubezky, Nir; Goykhman, Yaacov; Lahat, Guy; Yakir, Oz; Pelles, Sharon; Aizic, Asaf; Blachar, Arye; Stern, Naftali; Greenman, Yona 分享 收藏
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study Keizman, Daniel; Frenkel, Moshe; Peer, Avivit; Rosenbaum, Eli; Sarid, David; Leibovitch, Ilan; Mano, Roy; Yossepowitch, Ofer; Wolf, Ido; Geva, Ravit; Margel, David; Rouvinov, Keren; Stern, Anat; Dresler, Hadas; Kushnir, Igal; Eliaz, Isaac 分享 收藏
Collaborative privacy-preserving analysis of oncological data using multiparty homomorphic encryption Geva, Ravit; Gusev, Alexander; Polyakov, Yuriy; Liram, Lior; Rosolio, Oded; Alexandru, Andreea; Genise, Nicholas; Blatt, Marcelo; Duchin, Zohar; Waissengrin, Barliz; Mirelman, Dan; Bukstein, Felix; Blumenthal, Deborah T.; Wolf, Ido; Pelles-Avraham, Sharon; Schaffer, Tali; Lavi, Lee A.; Micciancio, Daniele; Vaikuntanathan, Vinod; Al Badawi, Ahmad; Goldwasser, Shafi 分享 收藏
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164 Pembrolizumab用于先前治疗的微卫星不稳定性高/错配修复缺陷的晚期结直肠癌: KEYNOTE-164的最终分析 Le, Dung T.; Diaz Jr, Luis A.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jaeger, Dirk; Hara, Hiroki; Burge, Matthew; O'Neil, Bert H.; Kavan, Petr; Yoshino, Takayuki; Guimbaud, Rosine; Taniguchi, Hiroya; Elez, Elena; Al-Batran, Salah-Eddin; Boland, Patrick M.; Cui, Yi; Leconte, Pierre; Marinello, Patricia; Andre, Thierry 分享 收藏
分享 收藏
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors Osher, Esther; Shalabna, Eiman; Klausner, Joseph M.; Greenman, Yona; Stern, Naftali; Shibolet, Oren; Scapa, Erez; Yakir, Oz; Shor, Dana Ben-Ami; Bar-Yishay, Iddo; Shamai, Sivan; Sofer, Yael; Lubezky, Nir; Goykhman, Yaacov; Lahat, Guy; Wolf, Ido; Pelles, Sharon; Aizic, Asaf; Blachar, Arye; Geva, Ravit 分享 收藏
分享 收藏
Phase 3 study of MK4280A (coformulated favezelimab and pembrolizumab) versus standard of care in previously treated PD-L1epositive metastatic colorectal cancer (mCRC) Kim, T.; Taieb, J.; Passhak, M.; Kim, T.; Kim, S.; Geva, R.; Hofsli, E.; Perl, G.; Yalcin, S.; Hubert, A.; Somer, B.; Wong, Z.; Wang, A.; Leconte, P.; Fogelman, D.; Heinemann, V. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ESMO Open.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
